Bristol Myers Squibb is committed to Arthritis research by making clinical trials available for all potential patients.
The list of studies below may change as studies are added or removed due to completion, so please check back often.
Click on the View Trial Details link below each clinical trial to learn more about the study
Select any "Check Your Eligibility" button on the website and answer a few questions about your diagnosis to see if you are a potential match to any arthritis clinical trial and refer yourself to a recruiting trial site in a location convenient for you
Talk to your doctor ABOUT participating in an Arthritis clinicial trial
A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment
A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease-modifying Anti-rheumatic Drugs
Bristol Myers Squibb is united by our mission to transform patient’s lives through science by discovering, developing, and delivering innovative medicines that help prevail over serious diseases. To that end, we are committed to doing our part to help ensure patients have a fair and just opportunity to achieve optimal health outcomes.
We are working to improve the recruitment of diverse patients with the goal that the clinical trial population becomes more reflective of the real-world population and the people impacted by the diseases studied.
We strongly recommend you contact BMS to report Side Effects (Adverse Events)
Side Effects (Adverse Events) and other reportable events are defined here
Report Side Effects (Adverse Events) or Product Quality Complaints: Medical Information